Becker's Healthcare February 6, 2025
As pharmaceutical companies push back against the 340B Drug Pricing Program, several states, including Utah, Colorado, Arkansas, Maine and Nebraska, are introducing legislation to protect the program and ensure continued access to discounted medications for safety-net hospitals and clinics.
The bills aim to address pharmaceutical restrictions and provide transparency, ensuring that hospitals can continue supporting low-income patients and funding critical services.
Here are seven notes:
- The 340B drug pricing program mandates drug manufacturers to provide discounted medications to safety-net hospitals and clinics serving low-income communities.
- Multiple states, including Utah, Colorado, Arkansas, Maine and Nebraska, have introduced bills to safeguard the 340B program, amid increasing restrictions from pharmaceutical companies.
- Utah’s bill, spearheaded by Rep. Steve...